MITAPIVAT SULFATE | AGIOS PHARMS INC | ||
EQ 5MG BASE,EQ 20MG BASE,EQ 50MG BASE | |||
No | No | ||
2041-Jul-31 | 2027-Feb-17 | ||
None | None | ||
None | No | ||
PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. |
0 | 0 | 0 |
Total Other Developers | 4 |
---|
Drugs with Suitability | No |
---|
EQ 5MG BASE | ** | ** | - | - | - |
EQ 20MG BASE | ** | ** | - | - | - |
EQ 50MG BASE | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com